December 7, 2020 10:20 PM | With information from EFE
15 minutes. The administration of Donald Trump rejected an offer presented by the pharmaceutical company Pfizer to buy additional doses of the coronavirus vaccine that it develops, as reported on Monday by the New York Times.
The information in the newspaper, which claims to have “sources familiar with the matter,” comes to light at a time when the country is trying to get more vaccines.
Also a day before Trump is scheduled to sign an executive order to “ensure that the US Government gives priority to getting vaccines to US citizens before shipping them to other nations.”
It is unknown, however, exactly what the order would result, which is contained in a statement. In addition, if it would eventually lead to expanding the number of doses contained in existing federal contracts.
The Pfizer vaccine, which it developed with Germany’s BioNTech, is a two-dose treatment. So the 100 million doses I would have bought USA they would serve to inoculate only 50 million people.
This vaccine is expected to be authorized this weekend by the US authorities, while that of another pharmaceutical company, Moderna, will also be authorized soon.
They deny Trump’s alleged rejection of Pfizer
Meanwhile, the United Kingdom will begin to inoculate the population this Tuesday with the Pfizer and BioNTech vaccine, becoming the first Western nation to begin mass vaccinations.
In addition, the European Union announced on November 11, two days after Pfizer presented the good results of its vaccine, that it reached an agreement with the pharmaceutical company for the purchase of 200 million doses.
For his part, a senior official denied in a call with journalists that Pfizer offered a greater number of vaccines this summer.
“That is false. We are in the middle of negotiations right now, but we will have all the doses to vaccinate the Americans who want it by the end of the second quarter of 2021,” he said.